BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 11499346)

  • 1. Prognostic factors in stage I ovarian carcinoma.
    Vergote I
    Verh K Acad Geneeskd Belg; 2001; 63(3):257-71; discussion 272-6. PubMed ID: 11499346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma.
    Vergote I; De Brabanter J; Fyles A; Bertelsen K; Einhorn N; Sevelda P; Gore ME; Kaern J; Verrelst H; Sjövall K; Timmerman D; Vandewalle J; Van Gramberen M; Tropé CG
    Lancet; 2001 Jan; 357(9251):176-82. PubMed ID: 11213094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic importance of intraoperative rupture of malignant ovarian epithelial neoplasms.
    Sainz de la Cuesta R; Goff BA; Fuller AF; Nikrui N; Eichhorn JH; Rice LW
    Obstet Gynecol; 1994 Jul; 84(1):1-7. PubMed ID: 8008300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Assessment of prognostic factors in common ovarian tumors of varying malignancy].
    Demeter A; Várkonyi T; Csapó Z; Szánthó A; Oláh J; Papp Z
    Magy Onkol; 2004; 48(3):259-65. PubMed ID: 15520877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.
    Chan JK; Tian C; Monk BJ; Herzog T; Kapp DS; Bell J; Young RC;
    Cancer; 2008 May; 112(10):2202-10. PubMed ID: 18348296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
    Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
    Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical value of morphometric and DNA flow cytometric variables as independent predictors of survival in epithelial ovarian carcinoma: a 5-year follow-up study.
    Veerman MM; van der Wurff AA; van de Water M; Kruitwagen RF; Feijen HW; Vos MC
    Int J Gynecol Pathol; 2009 Sep; 28(5):432-41. PubMed ID: 19696612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.
    Sherman ME; Mink PJ; Curtis R; Cote TR; Brooks S; Hartge P; Devesa S
    Cancer; 2004 Mar; 100(5):1045-52. PubMed ID: 14983501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic factors of common epithelial ovarian cancer treated by surgery and cisplatin based combination chemotherapy].
    Sasaki H; Ochiai K; Terashima Y; Mochizuki S; Soda T; Nishimura H; Yakushiji M; Hirabayashi M
    Gan No Rinsho; 1989 Oct; 35(13):1615-20. PubMed ID: 2585733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in patients with stage I epithelial ovarian cancer.
    Dembo AJ; Davy M; Stenwig AE; Berle EJ; Bush RS; Kjorstad K
    Obstet Gynecol; 1990 Feb; 75(2):263-73. PubMed ID: 2300355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Laparoscopic preliminary surgery of ovarian malignancies. Experiences from 127 German gynecologic clinics].
    Kindermann G; Maassen V; Kuhn W
    Geburtshilfe Frauenheilkd; 1995 Dec; 55(12):687-94. PubMed ID: 8582588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of risk factors for epithelial ovarian cancer recurrence].
    Liu S; Liu JH; Huang H; Peng XP; Wang YM
    Ai Zheng; 2003 Nov; 22(11):1197-200. PubMed ID: 14613652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic importance of preoperative CA-125 in International Federation of Gynecology and Obstetrics stage I epithelial ovarian cancer: an Australian multicenter study.
    Paramasivam S; Tripcony L; Crandon A; Quinn M; Hammond I; Marsden D; Proietto A; Davy M; Carter J; Nicklin J; Perrin L; Obermair A
    J Clin Oncol; 2005 Sep; 23(25):5938-42. PubMed ID: 16087942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma.
    Engelen MJ; Kos HE; Willemse PH; Aalders JG; de Vries EG; Schaapveld M; Otter R; van der Zee AG
    Cancer; 2006 Feb; 106(3):589-98. PubMed ID: 16369985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management and outcome of recurrent well-differentiated thyroid carcinoma.
    Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic factors in patients with stage I epithelial ovarian cancer].
    Wen HW; Liu SW
    Zhonghua Fu Chan Ke Za Zhi; 1994 Apr; 29(4):235-7, 255. PubMed ID: 8082450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative prognostic features in FIGO I ovarian cancer patients without postoperative treatment.
    Brugghe J; Baak JP; Wiltshaw E; Brinkhuis M; Meijer GA; Fisher C
    Gynecol Oncol; 1998 Jan; 68(1):47-53. PubMed ID: 9454660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the prognostic factors in patients with stage-I and -II ovarian cancer treated by an operation + irradiation variant].
    Tarlowska L; Czesnin K; Psikuta M; Romejko M
    Vopr Onkol; 1986; 32(3):36-44. PubMed ID: 3962255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ErbB-3 predicts survival in ovarian cancer.
    Tanner B; Hasenclever D; Stern K; Schormann W; Bezler M; Hermes M; Brulport M; Bauer A; Schiffer IB; Gebhard S; Schmidt M; Steiner E; Sehouli J; Edelmann J; Läuter J; Lessig R; Krishnamurthi K; Ullrich A; Hengstler JG
    J Clin Oncol; 2006 Sep; 24(26):4317-23. PubMed ID: 16896008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic factors of epithelial ovarian cancer in young women].
    Zhang R; Wu LY; Zhang WH; Li HJ; Li SM; Liu LY
    Zhonghua Zhong Liu Za Zhi; 2003 May; 25(3):264-7. PubMed ID: 12839691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.